Compare
5 stocks, side by sideRelative performance · rebased to 100
RGCKNSAINDVSUPNBCRX
| RGCRegencell Bioscience Holdings Limited | KNSAKiniksa Pharmaceuticals International, plc | INDVIndivior Pharmaceuticals, Inc. | SUPNSupernus Pharmaceuticals, Inc. | BCRXBioCryst Pharmaceuticals, Inc. | |
|---|---|---|---|---|---|
| Smart Score | - | 8/10 | 7/10 | 8/10 | 10/10 |
| Price | $7.49 | $56.89 | $41.29 | $44.75 | $9.90 |
| 1 month | -69% | +7.6% | +9.2% | -6.3% | +17% |
| 1 year | -67% | +96% | +197% | +41% | -0.30% |
| 5 year | - | +285% | +265% | +37% | -39% |
| P/E (TTM) | - | 36.1 | 19.4 | -89.5 | -5.5 |
| P/E vs sector | - | +14% | -38% | - | - |
| Market cap | $3.7B | $4.4B | $4.9B | $2.6B | $2.5B |
| Sector | Healthcare | Healthcare | Healthcare | Healthcare | Healthcare |
Risk / Return · past yearAnnualized return vs volatility, up-and-left is more reward for less risk.
Correlation · do they move together?Pairwise daily-return correlation over the past year, high = one bet, low = diversifying.